Department of Nuclear Medicine, Saitama Medical University International Medical Center, Hidaka City, Saitama Prefecture, Japan.
Clin Nucl Med. 2011 Mar;36(3):212-3. doi: 10.1097/RLU.0b013e318208f2e0.
Myxofibrosarcoma (MFS) has a spectrum of malignant fibroblastic lesions with variably myxoid stroma and pleomorphism. A 67-year-old man with a bulky mass on his chest wall was diagnosed with MFS. He underwent F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography for detection of metastasis. FDG positron emission tomography /computed tomography showed inhomogeneous high FDG uptake (max standardized uptake value, 10.1) in the bulky tumor with no evidence of metastasis, and the tumor was successfully resected. FDG uptake seemed to be reflected by the broad spectrum of pathologic heterogeneity. And MFS should be considered when making a diagnosis of inhomogeneous FDG-avid lesions in the bulky masses of soft tissue.
黏液纤维肉瘤(MFS)是一种具有不同程度黏液样基质和多形性的恶性纤维母细胞病变谱。一名 67 岁男性,胸壁有一个肿块,被诊断为 MFS。他接受了 F-18 氟脱氧葡萄糖(FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)检查以检测转移。FDG-PET/CT 显示在没有转移证据的巨大肿瘤中存在不均匀的高 FDG 摄取(最大标准化摄取值,10.1),并且成功地进行了肿瘤切除术。FDG 的摄取似乎反映了广泛的病理异质性。在软组织巨大肿块中出现不均匀 FDG 摄取病变时,应考虑黏液纤维肉瘤的诊断。